{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-116216","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.711767+00:00","generated_at":"2026-06-22T00:40:43.437545+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bio-Path Holdings raises $2.0M in registered direct offering with common warrants","bullets":["Sold 800,000 shares at $2.50/share for gross proceeds ~$2.0M; net proceeds ~$1.7M after fees and expenses.","Issued common warrants to buy 800,000 shares at $2.85; exercisable after 6 months, term 5.5 years.","ROTH Capital Partners acted as placement agent; cash fee of 7.0% of gross proceeds plus expense reimbursement up to $50,000.","Proceeds intended for working capital and general corporate purposes; closing expected November 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-116216","json":"https://secwatch.observer/filing/0001104659-22-116216.json","markdown":"https://secwatch.observer/filing/0001104659-22-116216.md","text":"https://secwatch.observer/filing/0001104659-22-116216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/0001104659-22-116216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/tm2230081d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:40:43.437545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4be1d5b194e5642087251275f0aaa826f1e226e0","claim":"BIO-PATH HOLDINGS, INC. entered into Purchase Agreements with several institutional and accredited investors valued at gross proceeds of approximately $2.0 million (effective 2022-11-06).","evidence_excerpt":"On November 6, 2022, Bio-Path Holdings, Inc. (the “Company”) and several institutional and accredited investors entered into securities purchase agreements (the “Purchase Agreements”), pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 800,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $2.50 and gross proceeds of approximately $2.0 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/0001104659-22-116216-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"several institutional and accredited investors"},{"label":"Value","value":"gross proceeds of approximately $2.0 million"},{"label":"Effective","value":"2022-11-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}